Hoffmann – La Roche Ltd | 23,76%
Novartis | 8,60%Â
Prilenia Neurotherapeutics Ltd | 17,41%
PTC Therapeutics | 11,45%
Uniqure | 7,23%
Wave Life Sciences | 12,50%
Revenue from 2022 | 2,89%
HSG Clinical Research Inc | 10,98%
Huntington Liga | 5,18%
